We’re not only bridging the barrier between mind and body, but we’re also making headlines with our innovative digital therapeutics.
PRESS RELEASES AND ANNOUNCEMENTS
Abdominal pain is the primary symptom of all IBS subtypes (IBS-C, IBS-D, and IBS-M), and is the number one reason patients seek treatment for their IBS. Regulora®… Read more
CHICAGO (October 31, 2019) — metaMe Health, Inc., a Chicago-based prescription digital therapeutics company committed to the treatment of gastrointestinal… Read more
metaMe Health, a Chicago-based prescription digital therapeutics company committed to the treatment of gastrointestinal (GI) conditions such as Irritable… Read more
COMPANY AND INDUSTRY NEWS
In just a few short years, digital therapeutics (DTx) have become an exciting, incredibly competitive new frontier in healthcare. For those not familiar… Read more
Digital therapeutics (DTx)—software that delivers a clinical mechanism of action, either alone or in combination with other standard-of-care treatments… Read more
Chicago Bootcamps featured metaMe Health in their list of the 60 Chicago Startups to Watch in 2020. The list highlights the most promising companies… Read more
STAY CONNECTED TO THE FUTURE OF
PRESCRIPTION DIGITAL THERAPIES
Join our mailing list. Or to become an investor, contact us directly.